Many doctors worry that older patients or those with other health issues are too risky for major surgery. This concern often stops people from getting life-saving treatments. A new look at data from a large trial challenges that fear. Researchers analyzed 245 adults who had minimally invasive esophagectomy for esophageal cancer. This surgery removes part of the esophagus using small incisions and cameras. The team tracked how often patients faced severe complications, defined as serious issues requiring major intervention or hospital stay. They also looked at how long patients stayed in the hospital or intensive care unit. The results were clear. Thirty-five point five percent of all patients had severe complications. This rate did not rise for older patients. Those aged 75 and older had a low rate of severe issues. Patients with higher scores for general health problems also did not face higher risks. Even those with multiple existing conditions remained safe. The study suggests that age and illness alone should not rule out surgery. Doctors can consider these patients for the procedure if they follow current safety guidelines. However, the analysis had limits. The group of frail patients was very small. This made it hard to draw firm conclusions about the safest surgery for the most vulnerable patients. Follow-up time was not reported either. While this study offers hope, it is based on secondary analysis of an RCT. Associations were found, but causation was not proven. Still, the message is strong. Older patients can be safe candidates for this operation.
Older esophageal cancer patients face no higher risk of severe complications with minimally invasive surgery
Photo by Europeana / Unsplash
What this means for you:
Age and health conditions do not increase severe complication risk for minimally invasive esophagectomy in esophageal cancer patients. More on Esophageal Cancer
FDA approves OPDIVO QVANTIG for multiple advanced cancer indications including renal cell carcinoma and melanoma FDA approves subcutaneous nivolumab combination for multiple advanced cancers
FDA · May 15, 2026
Systematic review and meta-analysis of ML with cfDNA for cancer detection across stages Simple blood test spots early cancer without scary scans
· May 15, 2026
Prolonged time-to-surgery after chemoradiotherapy improves preoperative quality of life in esophageal cancer Waiting Longer for Esophageal Cancer Surgery Backfires Despite Feeling Better
· May 14, 2026
Early time-of-day immune checkpoint inhibitor administration improves overall survival in advanced solid tumors Cancer Patients Live Longer When Immunotherapy Starts Early in Day
· May 5, 2026